India, March 5 -- To build India's first outcome-driven nutraceuticals brand

ZeroHarm Sciences, India's first nano-formulated plant-based nutraceutical brand, announced the successful closure of a Rs 65 crore funding round. Kotak Alternate Asset Managers, through its Kotak Life Sciences Fund I, has invested Rs 40 crore, while Alkemi Growth Capital, a healthcare and consumer wellness-focused venture fund, has invested Rs 25 crore. Cipher-Plexus was the exclusive financial advisor to the transaction.

The capital will be primarily deployed to build India's first "Trust over Promise" health platform - a model where supplement efficacy is demonstrated through measurable consumer health outcomes, not unverifiable marketing claims. Alongside t...